Bank of Nova Scotia Trims Stock Position in Humana Inc. $HUM

Bank of Nova Scotia trimmed its position in Humana Inc. (NYSE:HUM) by 68.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 77,288 shares of the insurance provider’s stock after selling 165,097 shares during the quarter. Bank of Nova Scotia owned about 0.06% of Humana worth $20,108,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Elevation Point Wealth Partners LLC acquired a new position in Humana in the second quarter valued at approximately $32,000. Mather Group LLC. acquired a new stake in Humana during the third quarter worth $34,000. AlphaCore Capital LLC acquired a new stake in Humana during the second quarter worth $39,000. Private Wealth Management Group LLC raised its position in Humana by 47.5% in the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock valued at $39,000 after purchasing an additional 48 shares during the period. Finally, BOKF NA raised its position in Humana by 4,125.0% in the third quarter. BOKF NA now owns 169 shares of the insurance provider’s stock valued at $44,000 after purchasing an additional 165 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on HUM. Oppenheimer set a $250.00 price target on Humana in a report on Thursday, February 12th. Morgan Stanley set a $146.00 price objective on shares of Humana in a report on Thursday, February 12th. JPMorgan Chase & Co. lowered their target price on shares of Humana from $274.00 to $180.00 and set a “neutral” rating for the company in a research note on Friday, February 13th. Deutsche Bank Aktiengesellschaft set a $180.00 price target on shares of Humana and gave the company a “hold” rating in a research report on Friday, February 13th. Finally, Jefferies Financial Group reduced their price target on shares of Humana from $310.00 to $235.00 and set a “buy” rating on the stock in a research note on Thursday, February 12th. Seven research analysts have rated the stock with a Buy rating, sixteen have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $225.48.

Humana Price Performance

HUM stock opened at $170.18 on Tuesday. The business’s fifty day moving average price is $210.78 and its 200 day moving average price is $246.62. Humana Inc. has a 12-month low of $163.60 and a 12-month high of $315.35. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.70. The company has a market capitalization of $20.43 billion, a PE ratio of 17.33, a P/E/G ratio of 1.77 and a beta of 0.44.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) EPS for the quarter, beating analysts’ consensus estimates of ($4.01) by $0.05. The company had revenue of $32.64 billion during the quarter, compared to analysts’ expectations of $32.08 billion. Humana had a return on equity of 11.43% and a net margin of 0.92%.Humana’s revenue for the quarter was up 11.3% on a year-over-year basis. During the same period last year, the business posted ($2.16) EPS. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, sell-side analysts anticipate that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be issued a $0.885 dividend. The ex-dividend date is Friday, March 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 2.1%. Humana’s payout ratio is 36.05%.

Insider Buying and Selling at Humana

In other Humana news, insider Sanjay K. Shetty bought 810 shares of the business’s stock in a transaction that occurred on Monday, February 23rd. The shares were purchased at an average cost of $185.21 per share, with a total value of $150,020.10. Following the purchase, the insider directly owned 11,657 shares in the company, valued at approximately $2,158,992.97. This represents a 7.47% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 0.20% of the company’s stock.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.